Fish Oil EPA and DHA Market Report – Research, Industry Analysis Reports and Market Demands

Global Fish Oil EPA and DHA Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Fish Oil EPA and DHA Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Fish Oil EPA
- 1.3.3 Fish Oil DHA
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Fish Oil EPA and DHA Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Dietary Supplements
- 1.4.3 Fortified Foods and Beverages
- 1.4.4 Infant Formula
- 1.4.5 Pharmaceuticals
- 1.4.6 Pet Foods
- 1.4.7 Others
1.5 Global Fish Oil EPA and DHA Market Size & Forecast
- 1.5.1 Global Fish Oil EPA and DHA Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Fish Oil EPA and DHA Sales Quantity (2021-2032)
- 1.5.3 Global Fish Oil EPA and DHA Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Fish Oil EPA and DHA by Manufacturer

3.1 Global Fish Oil EPA and DHA Sales Quantity by Manufacturer (2021-2026)
3.2 Global Fish Oil EPA and DHA Revenue by Manufacturer (2021-2026)
3.3 Global Fish Oil EPA and DHA Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Fish Oil EPA and DHA by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Fish Oil EPA and DHA Manufacturer Market Share in 2025
- 3.4.3 Top 6 Fish Oil EPA and DHA Manufacturer Market Share in 2025
3.5 Fish Oil EPA and DHA Market: Overall Company Footprint Analysis
- 3.5.1 Fish Oil EPA and DHA Market: Region Footprint
- 3.5.2 Fish Oil EPA and DHA Market: Company Product Type Footprint
- 3.5.3 Fish Oil EPA and DHA Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Fish Oil EPA and DHA Market Size by Region
- 4.1.1 Global Fish Oil EPA and DHA Sales Quantity by Region (2021-2032)
- 4.1.2 Global Fish Oil EPA and DHA Consumption Value by Region (2021-2032)
- 4.1.3 Global Fish Oil EPA and DHA Average Price by Region (2021-2032)
4.2 North America Fish Oil EPA and DHA Consumption Value (2021-2032)
4.3 Europe Fish Oil EPA and DHA Consumption Value (2021-2032)
4.4 Asia-Pacific Fish Oil EPA and DHA Consumption Value (2021-2032)
4.5 South America Fish Oil EPA and DHA Consumption Value (2021-2032)
4.6 Middle East & Africa Fish Oil EPA and DHA Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Fish Oil EPA and DHA Sales Quantity by Type (2021-2032)
5.2 Global Fish Oil EPA and DHA Consumption Value by Type (2021-2032)
5.3 Global Fish Oil EPA and DHA Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Fish Oil EPA and DHA Sales Quantity by Application (2021-2032)
6.2 Global Fish Oil EPA and DHA Consumption Value by Application (2021-2032)
6.3 Global Fish Oil EPA and DHA Average Price by Application (2021-2032)

7 North America

7.1 North America Fish Oil EPA and DHA Sales Quantity by Type (2021-2032)
7.2 North America Fish Oil EPA and DHA Sales Quantity by Application (2021-2032)
7.3 North America Fish Oil EPA and DHA Market Size by Country
- 7.3.1 North America Fish Oil EPA and DHA Sales Quantity by Country (2021-2032)
- 7.3.2 North America Fish Oil EPA and DHA Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Fish Oil EPA and DHA Sales Quantity by Type (2021-2032)
8.2 Europe Fish Oil EPA and DHA Sales Quantity by Application (2021-2032)
8.3 Europe Fish Oil EPA and DHA Market Size by Country
- 8.3.1 Europe Fish Oil EPA and DHA Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Fish Oil EPA and DHA Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Fish Oil EPA and DHA Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Fish Oil EPA and DHA Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Fish Oil EPA and DHA Market Size by Region
- 9.3.1 Asia-Pacific Fish Oil EPA and DHA Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Fish Oil EPA and DHA Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Fish Oil EPA and DHA Sales Quantity by Type (2021-2032)
10.2 South America Fish Oil EPA and DHA Sales Quantity by Application (2021-2032)
10.3 South America Fish Oil EPA and DHA Market Size by Country
- 10.3.1 South America Fish Oil EPA and DHA Sales Quantity by Country (2021-2032)
- 10.3.2 South America Fish Oil EPA and DHA Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Fish Oil EPA and DHA Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Fish Oil EPA and DHA Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Fish Oil EPA and DHA Market Size by Country
- 11.3.1 Middle East & Africa Fish Oil EPA and DHA Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Fish Oil EPA and DHA Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Fish Oil EPA and DHA Market Drivers
12.2 Fish Oil EPA and DHA Market Restraints
12.3 Fish Oil EPA and DHA Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Fish Oil EPA and DHA and Key Manufacturers
13.2 Manufacturing Costs Percentage of Fish Oil EPA and DHA
13.3 Fish Oil EPA and DHA Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Fish Oil EPA and DHA Typical Distributors
14.3 Fish Oil EPA and DHA Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Fish Oil EPA and DHA market size was valued at US$ 1704 million in 2025 and is forecast to a readjusted size of US$ 2132 million by 2032 with a CAGR of 3.3% during review period.
Fish oil is a kind of oil extracted from fatty fish. It is rich in eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and various n-3 polyunsaturated fatty acids (n-3PUFA), which are essential unsaturated fatty acids for the human body. EPA can clean up blood vessel waste, soften blood vessels and improve immunity, and is known as the "blood vessel scavenger"; DHA is often used for pregnant women and infants. By taking DHA, it can promote the normal growth and development of the brain, thus playing a so-called brain-boosting and intelligence-enhancing effect, commonly known as "brain gold".
Rising Burden of Chronic Diseases Fuels Preventive Nutrition: As cardiovascular diseases, diabetes, neurodegenerative disorders, and systemic inflammation become global public health challenges, demand for preventive and functional nutrition is rising. EPA is well-known for its anti-inflammatory and triglyceride-lowering effects, while DHA supports neural and retinal development. These health benefits position EPA and DHA as essential components of daily supplementation, increasingly recommended by healthcare professionals.
Growing Focus on Cognitive and Brain Health Accelerates DHA Demand: With aging populations and heightened awareness of childhood cognitive development, DHA is gaining traction as a key structural component of the brain and nervous system. DHA supplementation is now routine in prenatal supplements, infant formula, and cognitive support products for aging adults, making it a central growth driver in the omega-3 category.
Expanding Middle Class and Health-Conscious Consumers Boost Uptake: In emerging markets, especially in Asia-Pacific, the expanding middle class and rising health literacy are driving the shift from curative medicine to preventive self-care. Fish oil supplements are increasingly viewed as affordable and accessible wellness investments by families looking to maintain long-term health.
Pharmaceutical-Grade EPA Adoption Reinforces Clinical Value: Prescription EPA products like icosapent ethyl have demonstrated strong clinical benefits in reducing cardiovascular risk. As more regulatory bodies and health systems embrace these results, the pharmaceutical segment is emerging as a high-value growth pillar, pushing the omega-3 industry further into the healthcare domain.
Advancements in Purification Technology Improve Quality and Appeal: Historically, concerns over fishy taste, oxidation, and contamination hindered broader omega-3 adoption. Today, molecular distillation, supercritical CO₂ extraction, and re-esterification techniques have led to purer, better-tasting, and more bioavailable products, greatly enhancing consumer trust and satisfaction.
This report is a detailed and comprehensive analysis for global Fish Oil EPA and DHA market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Fish Oil EPA and DHA market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Fish Oil EPA and DHA market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Fish Oil EPA and DHA market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Fish Oil EPA and DHA market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fish Oil EPA and DHA
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fish Oil EPA and DHA market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KD Pharma, Croda, BASF, Yuwang Pharma, GC Rieber VivoMega, Pelagia (EPAX), Golden Omega, TASA, KinOmega Biopharm, Omega Protein, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Fish Oil EPA and DHA market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fish Oil EPA
Fish Oil DHA
Market segment by Application
Dietary Supplements
Fortified Foods and Beverages
Infant Formula
Pharmaceuticals
Pet Foods
Others
Major players covered
KD Pharma
Croda
BASF
Yuwang Pharma
GC Rieber VivoMega
Pelagia (EPAX)
Golden Omega
TASA
KinOmega Biopharm
Omega Protein
Huatai Phrama
AlaskOmega (Wiley Companies)
Jiangsu Auqi Marine Biotechnology
Sinomega Biotech Engineering
Xinzhou Marine Biological Products
Nu-Mega (Clover)
Skuny Bioscience
Renpu Pharmaceuticals
Polaris
Solutex
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fish Oil EPA and DHA product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fish Oil EPA and DHA, with price, sales quantity, revenue, and global market share of Fish Oil EPA and DHA from 2021 to 2026.
Chapter 3, the Fish Oil EPA and DHA competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fish Oil EPA and DHA breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Fish Oil EPA and DHA market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fish Oil EPA and DHA.
Chapter 14 and 15, to describe Fish Oil EPA and DHA sales channel, distributors, customers, research findings and conclusion.

Buy now